Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Vetrie

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nature|September 3, 2015
Cancer: Repositioned to kill stem cellsTessa Holyoake, David Vetrie
Seminars in Cancer Biology|August 6, 2017
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic optionsSteffen Koschmieder, David Vetrie
Human Molecular Genetics|September 11, 2004
Applications of genomic microarrays to explore human chromosome structure and functionNigel P Carter, David Vetrie
Blood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David Vetrie
Nature Reviews. Cancer|January 8, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AMLDavid Vetrie, G Vignir Helgason, Mhairi Copland
Frontiers in Cell and Developmental Biology|August 6, 2019
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CMLJane Bugler, Ross Kinstrie, Mary T Scott, et al.
Cancer Research|July 23, 2003
Gene expression profiling in polycythemia vera using cDNA microarray technologyAndrea Pellagatti, David Vetrie, Cordelia F Langford, et al.
Blood|November 9, 2013
Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALLYan Zhou, Sreenivasulu Kurukuti, Peter Saffrey, et al.
BMC Genomics|July 12, 2003
Whole-genome microarrays of fission yeast: characteristics, accuracy, reproducibility, and processing of array dataRachel Lyne, Gavin Burns, Juan Mata, et al.
Cancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nature|September 3, 2015
Cancer: Repositioned to kill stem cellsTessa Holyoake, David Vetrie
Seminars in Cancer Biology|August 6, 2017
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic optionsSteffen Koschmieder, David Vetrie
Human Molecular Genetics|September 11, 2004
Applications of genomic microarrays to explore human chromosome structure and functionNigel P Carter, David Vetrie
Blood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David Vetrie
Nature Reviews. Cancer|January 8, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AMLDavid Vetrie, G Vignir Helgason, Mhairi Copland
Frontiers in Cell and Developmental Biology|August 6, 2019
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CMLJane Bugler, Ross Kinstrie, Mary T Scott, et al.
Cancer Research|July 23, 2003
Gene expression profiling in polycythemia vera using cDNA microarray technologyAndrea Pellagatti, David Vetrie, Cordelia F Langford, et al.
Blood|November 9, 2013
Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALLYan Zhou, Sreenivasulu Kurukuti, Peter Saffrey, et al.
BMC Genomics|July 12, 2003
Whole-genome microarrays of fission yeast: characteristics, accuracy, reproducibility, and processing of array dataRachel Lyne, Gavin Burns, Juan Mata, et al.
Cancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.
Pageof 4